MDLN insider trading

Healthcare

Medline Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
197
Last 90 days
89
Buys / sells
2% / 13%
Market cap
$37.66B

About Medline Inc.

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.

Company website: www.medline.com

MDLN insider activity at a glance

FilingIQ has scored 197 insider transactions for MDLN since Dec 16, 2025. The most recent filing in our index is dated Mar 10, 2026.

Across the full history, 4 open-market purchases and 26 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on MDLN insider trades is 60.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Other Healthcare tickers with recent insider activity

Frequently asked

How many insider trades does FilingIQ track for MDLN?
FilingIQ tracks 197 Form 4 insider transactions for MDLN (Medline Inc.), covering filings from Dec 16, 2025 onwards. 89 of those were filed in the last 90 days.
Are MDLN insiders net buyers or net sellers?
Across the full Form 4 history for MDLN, 4 transactions (2%) were open-market purchases and 26 (13%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does MDLN insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is MDLN in?
Medline Inc. (MDLN) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $37.66B.

Methodology & sources

Every MDLN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.